Fear that new US government policies will promote abortion was raised this week in two statements issued by the United States Conference of Catholic Bishops (USCCB).
On Thursday, the U.S. Department of Health and Human Services published a proposed rule to reverse “The Protect Life Rule,” a regulation issued by the Trump Administration in 2019 to clearly separate abortion from family planning in the federal Title X family planning program. Archbishop Joseph F. Naumann of Kansas City in Kansas, chairman of the USCCB’s Committee on Pro-Life Activities, issued the following statement expressing profound disappointment over this action:
“This policy change will allow the Title X program to become an indirect funding avenue for abortion providers. In spite of explicit prohibitions in Federal law and clear congressional intent that abortion may not be a part of this program, it has repeatedly been coopted by abortion supporters as a funding stream for organizations, programs, and facilities that directly promote and provide abortions.
“While the USCCB has always had strong objections to government promotion and funding of contraceptives, we have also long supported clear financial and physical separation between Title X-funded projects and programs and facilities where abortion is a method of family planning. This proposed rule is terrible policy; it would reintegrate abortion into what is supposed to be a pre-pregnancy family planning program. I strongly urge the Biden Administration to suspend this proposed rule and leave the Title X program as it was intended and authorized to be – a program entirely separate from abortion.”
Earlier, the US Food and Drug Administration announced Tuesday that they will no longer be enforcing the “in-person dispensing requirement” for the chemical abortion pills during the remainder of the COVID-19 public health emergency. This requirement was put in place by public health officials over twenty years ago, under President Bill Clinton, as a necessary precondition to ensure that pregnant women do not have contraindications that would make the abortion pills even more unsafe and possibly deadly for the woman. Archbishop Joseph F. Naumann of Kansas City in Kansas, chairman of the U.S. Conference of Catholic Bishops’ Committee on Pro-Life Activities issued the following statement:
“It is difficult to see the FDA’s decision to not enforce important safety protocols as anything other than callous capitulation to the requests of abortion activists without regard for the health and safety of the women involved. An in-person evaluation by a medical professional is necessary to accurately determine the age of the baby (abortion pills are only approved for use in the first 70 days), whether the pregnancy is ectopic (which the woman has no way of knowing on her own), and to test and treat for Rh-incompatibility between mother and baby. Without this information and proper treatment, a woman’s health, future fertility, and life are placed in serious jeopardy. With this decision, not only are women being sold the lie that abortion will solve their problems, but also that chemical abortion is a safe and easy way to go about it. By pushing women away from medical oversight, abortion advocates are luring women into isolated, unsafe, and medically unwise decisions. The inalienable dignity of women and their unborn children deserves so much more.”
